Pharmaceutical compositions containing pyrimidine derivatives and their applications

TW202631144APending Publication Date: 2026-08-01GUANGDONG RAYNOVENT BIOTECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-12-04
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001071381_001
    Figure TWG2TA001071381_001
  • Figure TWG2TA001071381_002
    Figure TWG2TA001071381_002
  • Figure TWG2TA001071381_003
    Figure TWG2TA001071381_003
Patent Text Reader

Abstract

This disclosure relates to a pharmaceutical composition containing a pyrimidine derivative and its application. The pharmaceutical composition contains compound 1 as the active ingredient, and further includes a basic reagent and a solubilizer, wherein the molar ratio of the active ingredient to the total amount of the basic reagent and solubilizer is 1:0.80~3.50. The pharmaceutical composition disclosed herein can effectively improve the solubility of compound 1, ensure the stable release of compound 1 in vivo and in vitro, significantly improve the bioavailability of the pharmaceutical formulation, and provide a feasible solution for the clinical use of compound 1.
Need to check novelty before this filing date? Find Prior Art